Literature DB >> 8721589

Immunohistochemical study of primary and recurrent basal cell and metatypical carcinomas of the skin.

I A Kazantseva1, A N Khlebnikova, V R Babaev.   

Abstract

We investigated cell proliferation and expression of cytoskeletal proteins in 32 cases of primary basal cell carcinomas (BCC), 10 cases of recurrent BCC, and 10 cases of metatypical carcinomas (MTC). Paraffin-embedded biopsies were evaluated immunohistochemically with a battery of antibodies. Antibodies to proliferating cell nuclear antigen (PCNA) demonstrated comparatively low numbers of proliferating cells in 25 of 32 cases of primary BCC. In contrast, both recurrent BCC and MTC exhibited three to four times higher levels of proliferating cells than primary BCC. PCNA-positive cells were usually distributed uniformly throughout the lobules; at times, however, they were localized to the outer areas of those neoplasms, with a comparatively low level of proliferation index. Antibodies to keratin 17 strongly stained cells of all BCC cases, and antibodies to keratin 8 reacted with most of them. In contrast, the staining intensity of both types of keratin in MTC was decreased six to eight times as compared with all BCC. In addition, cells of eight BCC and three MTC reacted with antibodies to smooth muscle alpha-actin and myosin, neoplasms that did not differ by the number of PCNA-positive nuclei from carcinomas without contractile proteins. The differences in cell proliferation and keratin expression between BCC and MTC may be useful criteria for further distinguishing these carcinomas. The appearance of contractile proteins in some BCC and MTC may be the result of, or implies, myoepithelial differentiation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8721589     DOI: 10.1097/00000372-199602000-00006

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN: 0193-1091            Impact factor:   1.533


  7 in total

1.  Relapsing advanced metatypical basal cell carcinomas (MTBCC) of the face: surgical modalities.

Authors:  Georgi Tchernev; Anastasiya Atanasova Chokoeva; Plamen Kolev Penev; Julian Ananiev; Andreas Nowak; Yousef Bayyoud; Stanislav Philipov; José-Carlos Cardoso; Uwe Wollina
Journal:  Wien Med Wochenschr       Date:  2014-10-02

2.  Metatypical Basal cell carcinomas: a successful surgical approach to two cases with different tumor locations.

Authors:  Georgi Tchernev; Julian Ananiev; José Carlos Cardoso; Uwe Wollina
Journal:  Maedica (Buchar)       Date:  2014-03

3.  Diagnostic utility of cytokeratin 17 immunostaining in morpheaform basal cell carcinoma and for facilitating the detection of tumor cells at the surgical margins.

Authors:  Heidi Anderson-Dockter; Todd Clark; Satori Iwamoto; Ming Lu; David Fiore; Jane K Falanga; Vincent Falanga
Journal:  Dermatol Surg       Date:  2012-06-12       Impact factor: 3.398

4.  Basosquamous carcinoma of the head and neck: clinical and histologic characteristics and their impact on disease progression.

Authors:  Kai Wermker; Nikola Roknic; Katharina Goessling; Martin Klein; Hans-Joachim Schulze; Christian Hallermann
Journal:  Neoplasia       Date:  2015-03       Impact factor: 5.715

5.  Clinical and histopathological characteristics of primary and recurrent basal cell carcinoma: a retrospective study of the patients from a tertiary clinical centre in the northern Poland.

Authors:  Anna Płaszczyńska; Robert Skibiński; Martyna Sławińska; Wojciech Biernat; Aleksandra Lesiak; Roman J Nowicki; Michał Sobjanek
Journal:  Postepy Dermatol Alergol       Date:  2022-02-28       Impact factor: 1.837

Review 6.  Metatypical basal cell carcinoma: a clinical review.

Authors:  Mauro Tarallo; Emanuele Cigna; Riccardo Frati; Sergio Delfino; Daniele Innocenzi; Umberto Fama; Annamaria Corbianco; Nicolò Scuderi
Journal:  J Exp Clin Cancer Res       Date:  2008-11-07

7.  Giant Pendulous Carcinosarcoma - Squamous Cell Carcinoma-Type - of the Leg - A Case Report and Review of the Literature.

Authors:  Uwe Wollina; Ina Riedel; Mohammad R Abushika; Torello Lotti; Georgi Tchernev
Journal:  Open Access Maced J Med Sci       Date:  2018-01-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.